SPOTLIGHT Excitement builds for long-acting TB treatments, but research still at early stage 5 min 0 By Catherine Tomlinson for Spotlight
SPOTLIGHT OP-ED Competition law has again worked to fight a bad drug patent, but we need other solutions 6 min 0 By Fatima Hassan and Leena Menghaney for Spotlight
BHEKISISA Faster tests, shorter treatments — how new tech could help slow down drug-resistant TB 6 min 1 By Zano Kunene
BHEKISISA More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws 2 min 7 By Mia Malan for the Bhekisisa Centre for Health Journalism
BHEKISISA CENTRE FOR HEALTH JOURNALISM Is the future of South Africa’s TB plans locked up in the mysterious minds of teens? 7 min 0 By Joan van Dyk for the Bhekisisa Centre for Health Journalism
SPOTLIGHT Shorter, simpler drug-resistant TB treatment expected in SA later in 2022 6 min 0 By Catherine Tomlinson for Spotlight
SPOTLIGHT Minimising nasty side effects: Important TB drug is effective at lower dose, study finds 6 min 0 By Tiyese Jeranji and Marcus Low for Spotlight
SPOTLIGHT Drug-resistant TB breakthrough as new drug approved for use in United States after SA trials 6 min 0 By Spotlight
Op-Ed Support South Africa at UN – we need better & affordable TB medicines 5 min 0 By Sibongile Tshabalala Umunyana Rugege
South Africa New tuberculosis drugs are more effective and may be less toxic. Why are they still unavailable? 6 min 0 By Marelise Van Der Merwe
